{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2(1)"],"submitter":["Wimmer MR"],"pubmed_abstract":["<h4>Objective</h4>The coronavirus disease 2019 (COVID-19) pandemic has required healthcare systems and hospitals to rapidly modify standard practice, including antimicrobial stewardship services. Our study examines the impact of COVID-19 on the antimicrobial stewardship pharmacist.<h4>Design</h4>A survey was distributed nationally to all healthcare improvement company members.<h4>Participants</h4>Pharmacist participants were mostly leaders of antimicrobial stewardship programs distributed evenly across the United States and representing urban, suburban, and rural health-system practice sites.<h4>Results</h4>Participants reported relative increases in time spent completing tasks related to medication access and preauthorization (300%; <i>P</i> = .018) and administrative meeting time (34%; <i>P</i> = .067) during the COVID-19 pandemic compared to before the pandemic. Time spent rounding, making interventions, performing pharmacokinetic services, and medication reconciliation decreased.<h4>Conclusion</h4>A shift away from clinical activities may negatively affect the utilization of antimicrobials."],"journal":["Antimicrobial stewardship & healthcare epidemiology : ASHE"],"pagination":["e56"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9726570"],"repository":["biostudies-literature"],"pubmed_title":["The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey."],"pmcid":["PMC9726570"],"pubmed_authors":["Schulz LT","Jain R","Postelnick M","Schwei RJ","Brett M","Holubar M","Walraven C","Larry R","Wimmer MR","Fong K","Burgess DR","Njoku J","Pulia MS","Newland H","Hamel AG","Hale CM","Spivak ES"],"additional_accession":[]},"is_claimable":false,"name":"The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey.","description":"<h4>Objective</h4>The coronavirus disease 2019 (COVID-19) pandemic has required healthcare systems and hospitals to rapidly modify standard practice, including antimicrobial stewardship services. Our study examines the impact of COVID-19 on the antimicrobial stewardship pharmacist.<h4>Design</h4>A survey was distributed nationally to all healthcare improvement company members.<h4>Participants</h4>Pharmacist participants were mostly leaders of antimicrobial stewardship programs distributed evenly across the United States and representing urban, suburban, and rural health-system practice sites.<h4>Results</h4>Participants reported relative increases in time spent completing tasks related to medication access and preauthorization (300%; <i>P</i> = .018) and administrative meeting time (34%; <i>P</i> = .067) during the COVID-19 pandemic compared to before the pandemic. Time spent rounding, making interventions, performing pharmacokinetic services, and medication reconciliation decreased.<h4>Conclusion</h4>A shift away from clinical activities may negatively affect the utilization of antimicrobials.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-19T05:57:37.378Z","creation":"2025-04-19T05:57:37.378Z"},"accession":"S-EPMC9726570","cross_references":{"pubmed":["36483364"],"doi":["10.1017/ash.2022.37"]}}